Tarsus Pharmaceuticals Inc

TARS NASDAQ Santé & Biotech États-Unis US87650L1035
62.55 $
2.88 %

Tarsus Pharmaceuticals est spécialisée dans le développement de traitements ophtalmologiques pour diverses maladies des yeux, notamment la blépharite démadoxique.

Performance & Momentum

6 Months 25.32 %
1 Year 48.95 %
3 Years 233.94 %
5 Years 72.98 %

Similar stocks to Tarsus Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Tarsus Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases